Company: GLPG
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001558370-25-003806
Chunk: 222

Company: GALAPAGOS NV
Filing Date: 2025-03-27
Form: 20-F
Item: Item 6
Chunk 222
---
 vice president of corporate development at Myogen, Inc., which was acquired by Gilead in 2006. Mr. Dickinson is also a member of the Board of Directors of Sutter Health.
Oleg Nodelman is a Non-Executive non-independent member of our Board of Directors since October 7, 2024. Mr. Nodelman is the Founder and Portfolio Manager of EcoR1 Capital LLC, a biotech-focused investment advisory firm established in 2013, which invests in companies at all stages of research and development. With over twenty years of experience in biotech investing, Mr. Nodelman has expertise in all aspects of investment management and deep roots in the biotech and scientific communities. Before founding EcoR1, Mr. Nodelman was a portfolio manager at BVF Partners, one of the first hedge funds dedicated to the biotechnology sector. He currently serves as a Board Member for three publicly traded companies: Galapagos, AnaptysBio and Zymeworks. Mr. Nodelman has a Bachelor of Science in Foreign Service with a concentration in Science and Technology from Georgetown University. On December 13, 2024, the Autorité des Marchés Financiers (“AMF”), the entity that regulates the French financial markets, fined Mr. Nodelman and EcoR1 Capital LLC (the “Fund”) €3.0 million and €7.0 million, respectively, for a strict liability violation of a market abuse regulation and reporting obligations for holders that exceed or fall below ownership of five percent of an issuer’s equity capital that is listed on Euronext Paris. Mr. Nodelman and the Fund disagree with the AMF’s ruling and, in February 2025, submitted an appeal, which they intend to pursue.
The following table sets forth certain information with respect to our Board of Directors’ voluntary self-identified 

​
159

gender and racial characteristics and LGBTQ+ status for 2024: 

                           ​                               ​      ​       ​     ​       ​                   ​           
------------------------------------------------------------------------------------------------------------------------
​                                                              ​         ​      ​   ​                                   
Country of Principal Executive Offices                         Belgium   ​      ​   ​            ​                      
Foreign Private Issuer                                         Yes       ​      ​   ​            ​                      
Disclosure prohibited under Home Country Law               ​   No        ​      ​   ​            ​                      
Total number of Board members                              ​   9         ​      ​   ​            ​                      
​                                                          ​   Female    Male   ​   Non-binary